[Possibilities of intensive therapy of systemic inflammatory response syndrome during purulent and septic complications in obstetrics and gynecology].
Kolesnichenko
A P
AP
Gritsan
A I
AI
Gritsan
G V
GV
Skorobogatov
A Iu
AIu
D018806:APACHE; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use; D001777:Blood Coagulation / Q000187:drug effects; D003422:Critical Care / Q000379:methods*; D005260:Female; D005831:Genital Diseases, Female / Q000097:blood / Q000150:complications / Q000628:therapy*; D005836:Genitalia, Female / Q000601:surgery; D006439:Hemodynamics / Q000502:physiology; D006801:Humans; D007813:Laparotomy; D010956:Plasmapheresis; D012121:Respiration, Artificial; D015656:Respiratory Mechanics / Q000502:physiology; D018746:Systemic Inflammatory Response Syndrome / Q000097:blood / Q000209:etiology / Q000628:therapy*
D000900:Anti-Bacterial Agents; D000925:Anticoagulants